证券时报·数据宝统计显示，公司今日公布了半年报，共实现营业收入4.91亿元，同比下降5.18%，实现 净利润7545.24万元，同比增长224.95%，基本每股收益为0.16元。 8月22日锦和商管发布2025半年度分配预案，拟10派1.1元（含税），预计派现金额合计为5197.50万元。 派现额占净利润比例为68.88%，这是公司上市以来，累计第7次派现。 公司上市以来历次分配方案一览 | 日期 | 分配方案 | 派现金额合计（亿元） | 股息率（%） | | --- | --- | --- | --- | | 2025.06.30 | 10派1.1元（含税） | 0.52 | 1.83 | | 2024.12.31 | 10派2.2元（含税） | 1.04 | 4.42 | | 2024.06.30 | 10派2.2元（含税） | 1.04 | 4.46 | | 2023.06.30 | 10派2.2元（含税） | 1.04 | 3.98 | | 2022.06.30 | 10派2.2元（含税） | 1.04 | 3.61 | | 2020.12.31 | 10派2.2元（含税） | 1.04 | 1.9 ...

公司上市以来历次分配方案一览 两融数据显示，该股最新融资余额为5905.25万元，近5日增加246.17万元，增幅为4.35%。 | 日期 | 分配方案 | 派现金额合计（亿元） | 股息率（%） | | --- | --- | --- | --- | | 2025.06.30 | 10派1元（含税） | 1.17 | 0.80 | | 2024.12.31 | 10派3元（含税） | 3.51 | 2.43 | | 2024.06.30 | 10派2元（含税） | 2.34 | 1.76 | | 2023.12.31 | 10派4.5元（含税） | 5.26 | 4.52 | | 2022.12.31 | 10派3.5元（含税） | 3.63 | 3.01 | | 2021.12.31 | 10转增3派5元（含税） | 3.99 | 5.81 | | 2020.12.31 | 10派4元（含税） | 3.10 | 6.39 | | 2019.12.31 | 10派4元（含税） | 3.03 | 5.66 | | 2018.12.31 | 10派3.5元（含税） | 2.65 | 3.56 | | 2017. ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 Contemporary Amperex Technology Co., Limited 寧德時代新能源科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：3750） 海外監管公告 2025年半年度報告摘要 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列寧德時代新能源科技股份有限公司（「本公司」）於深圳證券交易所網站 （ http://www.szse.cn /）及巨潮資訊網( www.cninfo.com.cn )所發佈之《寧德時代新能 源科技股份有限公司2025年半年度報告摘要》，僅供參閱。 承董事會命 寧德時代新能源科技股份有限公司 董事長、執行董事兼總經理 曾毓群先生 中國•寧德，二零二五年七月三十日 证券代码：300750 证券简称：宁德时代 公告编号：2025-064 宁德时代新能源科技股份有限公司 2025 年半年度报告摘要 一、重要提示 ...

Core Viewpoint - The company,虹软科技 (688088.SH), announced a proposal for a cash dividend plan for the first half of 2025, contingent on meeting profit distribution conditions, suggesting a cash dividend amount of no less than 60% and no more than 100% of the net profit attributable to shareholders during that period [1] Group 1 - The actual controller, chairman, and general manager Hui Deng proposed the cash dividend plan [1] - The suggested cash dividend is based on the net profit attributable to the company's shareholders for the first half of 2025 [1] - The proposed cash dividend amount is set to be between 60% and 100% of the net profit for the specified period [1]

Group 1 - The core point of the announcement is the approval of the 2024 annual dividend distribution plan by the company's shareholders, which includes a cash dividend of 0.135 yuan per 10 shares, totaling approximately 52.84 million yuan [1][5][3] - The dividend distribution is based on the company's total share capital of 3,914,253,923 shares, and there will be no capital reserve conversion or bonus shares issued [1][5] - The dividend will be distributed to all shareholders registered by the close of trading on July 3, 2025, with the ex-dividend date set for July 4, 2025 [6][7] Group 2 - The company has confirmed that there will be no changes to the total share capital from the announcement of the dividend plan until its implementation [2] - The distribution method involves direct transfer of cash dividends to shareholders' accounts through their securities companies on the ex-dividend date [8] - The company will adjust the exercise price of its stock option incentive plan according to the distribution of dividends, following relevant legal and regulatory procedures [9] Group 3 - The company has provided guarantees for its subsidiaries, with a total financing guarantee limit of up to 4.9 billion yuan approved by the board and shareholders [13] - Recent agreements include a maximum guarantee of 10 million yuan for Guangzhou Meinian Health Medical Clinic Co., Ltd. with Huaxia Bank [14] - Additional guarantees have been signed with various banks for different subsidiaries, including amounts of 1 million yuan to 7 million yuan for several entities [15][16][67]

Overview - Since the beginning of 2025, the A-share market has maintained a slight net inflow of funds, with the annual net inflow accounting for 1.1% of the free float market value as of May 22, 2025. Excluding private equity and insurance funds, the net outflow is approximately 0.1%, indicating a tight balance in the funding situation for the year [7][8][9]. Monthly Trends - In April 2025, there was a slight net outflow of funds amounting to 778 million, representing 0.01% of the circulating market value. However, in May, the situation improved with a net inflow of 1942 million, raising the net inflow ratio to 0.5% [13][17]. - The financing balance saw a significant decrease in April, dropping by 1226.21 million, but rebounded slightly in May with an increase of 211.58 million [18][19]. Fund Inflows and Outflows - In April 2025, the stock-type ETF saw a substantial net inflow of 1876.9 million, but turned to a net outflow of 422.95 million by May 22. Overall, the ETF funds recorded a net inflow of 506 million for the year [13][18]. - Insurance funds are expected to increase further, with the balance of insurance company investments reaching 349312.14 billion, an increase of 16731.92 billion from the previous quarter [18][19]. Company Actions - The total amount of share buybacks announced by listed companies in April 2025 was 1588.09 million, significantly higher than in March. By May 22, the cumulative buyback amount for the year reached 4095.64 million [18][19]. - The dividend payout in April 2025 was notably strong, with the dividend rate remaining at historically high levels [19]. Equity Financing - The scale of equity financing continued to decline, with April's financing amount at 432.06 million, a slight decrease from March. By May 22, the financing scale was recorded at 80.16 million, indicating a low level [19].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600572 证券简称：康恩贝 公告编号：临2025-012 姜毅董事长提请公司董事会就本项提议予以研究，拟定2024年度利润分配预案报董事会、股东大会审议 确定，其本人承诺将在相关会议审议该事项时投"赞成"票。 三、董事会有关说明 （一）经公司于2024年1月22日召开的第十届董事会第三十七次（临时）会议审议通过，同意公司使用2 亿元至4亿元区间的自有资金通过上海证券交易所以集中竞价交易方式回购公司股份。回购已于2024年7 月21日实施完成，累计回购公司股份6,357.9048万股，使用资金总额29,992.41万元。根据《上海证券交 易所上市公司自律监管指引第7号一回购股份》相关规定，公司回购专户中的股份不享有分红权。 浙江康恩贝制药股份有限公司 关于收到董事长2024年度分红事宜提议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 浙江康恩贝制药股份有限公司（以下简称"公司""本公司"）董事会于2025年4月11日收到公司董事长姜 毅先生提交的《关于公司 ...